The "drip-and-ship" approach: Starting IV t-PA for acute ischemic stroke at outside hospitals prior to transfer to a regional Stroke Center

Connecticut Medicine

Volumn 69, Issue 10, 2005, Pages 613-620

  Silverman, Isaac E ^a,b,c   Beland, Dawn K ^a   Chhabra, Jyoti ^a   McCullough, Louise D ^a,b  

^a HARTFORD HOSPITAL   (United States)

^b UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CATHETERIZATION; DRUG DELIVERY SYSTEM; DRUG SAFETY; EMERGENCY TREATMENT; EVALUATION; HEALTH CENTER; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; OUTCOMES RESEARCH; PATIENT TRANSPORT; RETROSPECTIVE STUDY; STROKE; SYMPTOMATOLOGY;

EID: 28244473347     PISSN: 00106178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Kleindorfer D, Kissela B, Schneider A, et al: Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: A population-based study. Stroke 2004; 35:27e-29.
2. Bravata D, Kim N, Concato J, et al: Thrombolysis for acute stroke in routine clinical practice. Arch Intern Med 2002; 162:1994-2001.
3. Silverman I, Beland D, Bohannon R, et al: Expanding the range of therapies for acute ischemic stroke: The early experience of the regional Stroke Center at Hartford Hospital. Conn Med 2004; 68:419-29.
4. Starkman S: Results of the combined MERCI I-II (Mechanical Embolus Removal in Cerebral Ischemia) Trials [abstract]. Stroke 2004; 35:240.
5. Lewandowski C, Frankel M, Tomsick T, et al: Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke 1999; 30:2598-605.
6. Marler JR, Tilley BC, Lu M, et al: Early stroke treatment associated with better outcome: The NINDS rt-PA Stroke Study. Neurology 2000; 55:1649-55.
7. Abciximab Emergent Stroke Treatment Trial Investigators: Emergency administration of abciximab for treatment of patients with acute ischemic stroke: Results of a randomized phase 2 trial. Stroke 2005; 36:880-90.
8. Smith W, Sung G, Starkman S, et al: Safety and efficacy of mechanical embolectomy in acute ischemic stroke: Results of the MERCI Trial. Stroke 2005; 36:1432-40.
9. Furlan A, Higashida R, Katzan I, Abou-Chebl A: Intra-arterial thrombolysis in acute ischemic stroke. In: Lyden P. ed. Thrombolytic Therapy for Stroke. Totowa, NJ: Humana Press, 2001:175-95.
10. Caplan L: The case against the present guidelines for stroke thrombolysis: The present recommendations for clinical use should be modified. In: Lyden P. ed. Thrombolytic Therapy for Stroke. Totowa, NJ: Humana Press, 2001:223-35.
11. Broderick J, Kothari R: Combinations of intravenous and intra-arterial thrombolysis. In: Lyden P, ed. Thrombolytic Therapy for Stroke. Totowa, NJ: Humana Press, 2001:197-208.
12. Zaidat O, Suarez J, Santillan C, et al: Response to intra-arterial and combined intravenous and intra-arterial thrombolytic therapy in patients with distal internal carotid artery occlusion. Stroke 2002; 33:1821-7.
13. Flaherty ML, Woo D, Kissela B, et al: Combined IV and intra-arterial thrombolysis for acute ischemic stroke. Neurology 2005; 64:386-8.
14. Alexandrov AV, Grotta JC: Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator. Neurology 2002; 59:862-7.
15. Alexandrov AV, Burgin WS, Demchuk AM, et al: Speed of intracranial clot lysis with intravenous tissue plasminogen activator therapy: Sonographic classification and short-term improvement. Circulation 2001; 103:2897-902.
16. IMS Study Investigators T: Combined intravenous and intra-arterial recanalization for acute ischemic stroke: The interventional management of stroke study. Stroke 2004; 35:904-11.
17. Alexandrov AV, Molina CA, Grotta JC, et al: Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med 2004; 351:2170-8.
18. Alexandrov A, Demchuk A, Felberg R, et al: High rate of complete recanalization and dramatic clinical recovery during tPA infusion when continuously monitored with 2-MHz transcranial Doppler monitoring. Stroke 2000; 31:610-4.
19. Daffertshofer M, A AG, Ringleb P, et al: Transcranial low-frequency ultrasound-dediated thrombolysis in brain ischemia: Increased risk of hemorrhage with combined ultrasound and tissue plasminogen activator. Results of a phase II clinical trial. Stroke 2005; 36.
20. Rymer MM, Thurtchley D, Summers D: Expanded modes of tissue plasminogen activator delivery in a comprehensive stroke center increases regional acute stroke interventions. Stroke 2003; 34:58e-60.
21. Wang D, Rose J, Honings D, et al: Treating acute stroke patients with intravenous tPA: The OSF stroke network experience. Stroke 2000; 31:77-81.
22. Frey JL, Jahnke HK, Goslar PW, et al: tPA by telephone: Extending the benefits of a comprehensive stroke center. Neurology 2005; 64:154-6.
23. Silliman SL, Quinn B, Huggett V, Merino JG: Use of a field-to-stroke center helicopter transport program to extend thrombolytic therapy to rural residents. Stroke 2003; 34:729-33.
24. Chalela J, Kasner S, Jauch E, Pancioli A: Safety of air medical transportation after tissue plasminogen activator administration in acute ischemic stroke. Stroke 2000; 30:2366-8.
25. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333:1581-7.
26. Katzan IL, Hammer MD, Furlan AJ, et al: Quality improvement and tissue-type plasminogen activator for acute ischemic stroke: A Cleveland update. Stroke 2003; 34:799-800.
27. Adams J, HP, Davis P, Leira E, et al: Baseline NIH stroke scale score strongly predicts outcome after stroke: A report of the trial of org 10172 in acute stroke treatment (TOAST). Neurology 1999; 53:126-31.